Cargando…

Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome

BACKGROUND: Malignancies, especially lymphoma, are a common cause of adult secondary HLH and an independent risk factor for the prognosis of HLH patients. METHODS: Patients with lymphoma alone or concurrent lymphoma-associated phagocytic syndrome (LAHS) admitted to Beijing Friendship Hospital from J...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Shuyan, Jin, Zhili, He, Lingbo, Zhang, Ruoxi, Liu, Menghan, Hua, Zhengjie, Wang, Zhao, Wang, Yini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685250/
https://www.ncbi.nlm.nih.gov/pubmed/34938663
http://dx.doi.org/10.3389/fonc.2021.788056
_version_ 1784617793628405760
author Yao, Shuyan
Jin, Zhili
He, Lingbo
Zhang, Ruoxi
Liu, Menghan
Hua, Zhengjie
Wang, Zhao
Wang, Yini
author_facet Yao, Shuyan
Jin, Zhili
He, Lingbo
Zhang, Ruoxi
Liu, Menghan
Hua, Zhengjie
Wang, Zhao
Wang, Yini
author_sort Yao, Shuyan
collection PubMed
description BACKGROUND: Malignancies, especially lymphoma, are a common cause of adult secondary HLH and an independent risk factor for the prognosis of HLH patients. METHODS: Patients with lymphoma alone or concurrent lymphoma-associated phagocytic syndrome (LAHS) admitted to Beijing Friendship Hospital from January 2016 to December 2020 were enrolled in this study. FINDINGS: There were 348 lymphoma patients, 104 concurrent with LAHS. The pathological type of lymphoma without LAHS was dominated by B-cell lymphoma, while those with LAHS were T/NK-cell lymphoma predominantly (p < 0.001). Superficial lymph node enlargement was more significant in patients with B-LAHS (p = 0.006), while patients with T/NK-LAHS had lower neutrophil counts (p = 0.005), lower fibrinogen levels (p < 0.001), higher transaminase levels, and more co-infection with EBV (p < 0.001). B-LAHS had significantly higher IL-10 levels than with T/NK-LAHS (p = 0.006), and NK/T-LAHS had significantly higher IP-10 levels than other T-LAHS (p = 0.008). Age, platelet count, IPI, history of NK/T lymphoma, and no remission of HLH were independent risk factors for prognosis in patients with non-Hodgkin lymphoma-associated phagocytic syndrome (NHL-LAHS), and a prognostic risk score model for NHL-LAHS was developed. CONCLUSION: LAHS is a life-threatening disease with a poor prognosis. The prognostic risk score model for NHL-LAHS with a good fit and validation for the test has value for clinical application.
format Online
Article
Text
id pubmed-8685250
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86852502021-12-21 Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome Yao, Shuyan Jin, Zhili He, Lingbo Zhang, Ruoxi Liu, Menghan Hua, Zhengjie Wang, Zhao Wang, Yini Front Oncol Oncology BACKGROUND: Malignancies, especially lymphoma, are a common cause of adult secondary HLH and an independent risk factor for the prognosis of HLH patients. METHODS: Patients with lymphoma alone or concurrent lymphoma-associated phagocytic syndrome (LAHS) admitted to Beijing Friendship Hospital from January 2016 to December 2020 were enrolled in this study. FINDINGS: There were 348 lymphoma patients, 104 concurrent with LAHS. The pathological type of lymphoma without LAHS was dominated by B-cell lymphoma, while those with LAHS were T/NK-cell lymphoma predominantly (p < 0.001). Superficial lymph node enlargement was more significant in patients with B-LAHS (p = 0.006), while patients with T/NK-LAHS had lower neutrophil counts (p = 0.005), lower fibrinogen levels (p < 0.001), higher transaminase levels, and more co-infection with EBV (p < 0.001). B-LAHS had significantly higher IL-10 levels than with T/NK-LAHS (p = 0.006), and NK/T-LAHS had significantly higher IP-10 levels than other T-LAHS (p = 0.008). Age, platelet count, IPI, history of NK/T lymphoma, and no remission of HLH were independent risk factors for prognosis in patients with non-Hodgkin lymphoma-associated phagocytic syndrome (NHL-LAHS), and a prognostic risk score model for NHL-LAHS was developed. CONCLUSION: LAHS is a life-threatening disease with a poor prognosis. The prognostic risk score model for NHL-LAHS with a good fit and validation for the test has value for clinical application. Frontiers Media S.A. 2021-12-06 /pmc/articles/PMC8685250/ /pubmed/34938663 http://dx.doi.org/10.3389/fonc.2021.788056 Text en Copyright © 2021 Yao, Jin, He, Zhang, Liu, Hua, Wang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yao, Shuyan
Jin, Zhili
He, Lingbo
Zhang, Ruoxi
Liu, Menghan
Hua, Zhengjie
Wang, Zhao
Wang, Yini
Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
title Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
title_full Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
title_fullStr Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
title_full_unstemmed Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
title_short Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome
title_sort clinical features and prognostic risk prediction of non-hodgkin lymphoma-associated hemophagocytic syndrome
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685250/
https://www.ncbi.nlm.nih.gov/pubmed/34938663
http://dx.doi.org/10.3389/fonc.2021.788056
work_keys_str_mv AT yaoshuyan clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome
AT jinzhili clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome
AT helingbo clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome
AT zhangruoxi clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome
AT liumenghan clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome
AT huazhengjie clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome
AT wangzhao clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome
AT wangyini clinicalfeaturesandprognosticriskpredictionofnonhodgkinlymphomaassociatedhemophagocyticsyndrome